BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37454491)

  • 21. Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.
    Carr JC; Boese EA; Spanheimer PM; Dahdaleh FS; Martin M; Calva D; Schafer B; Thole DM; Braun T; O'Dorisio TM; O'Dorisio MS; Howe JR
    Surgery; 2012 Dec; 152(6):998-1007. PubMed ID: 23158174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher IL-6 peri-tumoural expression is associated with gastro-intestinal neuroendocrine tumour progression.
    Pereira SS; Pereira R; Santos AP; Costa MM; Morais T; Sampaio P; Machado B; Afonso LP; Henrique R; Monteiro MP
    Pathology; 2019 Oct; 51(6):593-599. PubMed ID: 31466863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
    Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
    Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.
    Li SC; Martijn C; Cui T; Essaghir A; Luque RM; Demoulin JB; Castaño JP; Öberg K; Giandomenico V
    PLoS One; 2012; 7(10):e48411. PubMed ID: 23119007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine Neoplasms of the Small Bowel and Pancreas.
    Clift AK; Kidd M; Bodei L; Toumpanakis C; Baum RP; Oberg K; Modlin IM; Frilling A
    Neuroendocrinology; 2020; 110(6):444-476. PubMed ID: 31557758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).
    Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
    JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry.
    Kollar A; Bütikofer L; Ochsenbein A; Stettler C; Trepp R
    Swiss Med Wkly; 2020 Jan; 150():w20176. PubMed ID: 31940430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
    Kajtazi Y; Kaemmerer D; Sänger J; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2481-2493. PubMed ID: 31451931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway.
    Estrella JS; Taggart MW; Rashid A; Abraham SC
    Hum Pathol; 2014 Oct; 45(10):2051-8. PubMed ID: 25149552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
    Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
    Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
    Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
    Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
    de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
    J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
    Drozdov I; Svejda B; Gustafsson BI; Mane S; Pfragner R; Kidd M; Modlin IM
    PLoS One; 2011; 6(8):e22457. PubMed ID: 21853033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors.
    Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C
    Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors.
    Chen P; Wang Q; Xie J; Kwok HF
    Semin Cancer Biol; 2019 Oct; 58():80-89. PubMed ID: 31054326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine proliferations in inflammatory bowel disease: differentiating neuroendocrine tumours from neuroendocrine cell micronests.
    Wong M; Larson BK; Dhall D
    Histopathology; 2019 Feb; 74(3):415-423. PubMed ID: 30303561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
    Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.